Leaflet MYCOBUTIN 150mg capsules


Indicated for: tuberculosis

Route of administration: oral

Substance: rifabutin (antibacterial antibiotic)

ATC: J04AB04 (Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics)

Rifabutin is an antibiotic used for the prevention and treatment of Mycobacterium avium complex (MAC) infections in patients with HIV/AIDS or other conditions that weaken the immune system. It works by inhibiting bacterial RNA synthesis, killing the bacteria.

The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen to prevent the development of bacterial resistance.

Patients should be aware of potential side effects, such as nausea, abdominal pain, or changes in urine color. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, abdominal pain, and changes in urine color. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about MYCOBUTIN 150mg

  • Substance: rifabutin
  • Date of last drug list: 01-07-2013
  • Commercial code: W05430001
  • Concentration: 150mg
  • Pharmaceutical form: capsules
  • Quantity: 30
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).